ABUS vs CEG · P/E 5.4, rev $6.2M vs P/E 23, rev $25.53B
Arbutus Biopharma Corp (ABUS) versus Constellation Energy Corp (CEG) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Constellation Energy Corp (CEG) is a utilities - independent power producers company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported CEG revenue for 2025-12-31 was $25.53B. Net income was $2.32B. Revenue was up 8.3% from 2024-12-31 to 2025-12-31. CEG currently screens at market cap $96.25B and trailing P/E 23.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. CEG currently screens at market cap $96.25B and trailing P/E 23.4.
Not investment advice. Open the ABUS and CEG stock pages for the full models.
Not investment advice.